MYC and Miyoshi myopathy: The recent finding by Bolomsky et al. [34] showing that PTC-209 reduced the expression of MM survival genes such as c-MYC urged us to evaluate the efficacy of PTC-209 as anti-MM agent also in combination with the BET bromodomains inhibitor JQ1.